PubMed · 2325590
Differences between responsive and intractable chronic lymphocytic leukemia.
Abstract
About 19-26% of patients with chronic lymphocytic leukemia (CLL) have intractable disease resistant to chemotherapy, have a relatively short median survival time and are responsive to splenectomy. Lymphocytes from patients with intractable CLL are resistant in vitro to X-irradiation and to colchicine. Responsive CLL is an accumulative disease while intractable CLL is a proliferative disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R Schrek. 1990. Differences between responsive and intractable chronic lymphocytic leukemia.. https://doi.org/10.1016/0306-9877(90)90001-u
Cite the original work for its findings. Save a collection to share your selection of sources.